The initial public offer of Anthem Biosciences received bids for 14,47,66,596 shares as against 4,40,70,682 shares on offer, according to stock exchange data at 17:00 IST on Tuesday (15 July 2025).

According to market observers, shares of the company are available at a premium of ₹101 in the grey market today ...

Indian drugmaker Anthem Biosciences' ANTH.NS $395 million IPO was fully subscribed on the second day of bidding on Tuesday, ...

Anthem Biosciences' initial share sale received bids for 14,47,66,596 shares, as against 4,40,70,682 shares on offer, ...

The Rs 3,395 crore Initial Public Offering (IPO) of Anthem Biosciences, the Bangalore-based contract research, development, ...

Anthem Biosciences, ₹3,395 crore IPO was fully subscribed by Day 2, with strong interest from non-institutional investors, ...

With a unique business model rooted in innovation-led drug development services, the company is betting big on global ...

Anthem ticks all the boxes. But with lofty valuations and limited margin headroom, analysts warn the IPO may not deliver ...

With big pharma diversifying away from China, Anthem is well-positioned to capture outsourced CRDMO demand, especially in ...

Anthem Biosciences' IPO fully subscribed, investors optimistic about growth prospects amid global pharma shift from China to ...

Anthem Biosciences' IPO witnessed strong investor interest, being oversubscribed 2.08 times on Day 2, driven by NIIs.